Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential

Vaccine

Volumn 23, Issue 10, 2005, Pages 1265-1272

  Chaitra, M G ^a   Hariharaputran, Sridhar ^a   Chandra, Nagasuma R ^a   Shaila, M S ^a   Nayak, R ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

HLA class I binding prediction; Molecular modeling; PE and PPE proteins; T cell epitope

Indexed keywords

BACTERIAL PROTEIN; EPITOPE; HLA ANTIGEN CLASS 1; MYCOBACTERIUM VACCINE; PROTEOME;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; BACTERIAL GENOME; BINDING AFFINITY; COMPARATIVE STUDY; CORRELATION ANALYSIS; MOLECULAR MODEL; MULTIGENE FAMILY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; T LYMPHOCYTE; TUBERCULOSIS;

ALLELES; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; EPITOPES; GENES, MHC CLASS I; HALF-LIFE; HISTOCOMPATIBILITY TESTING; HUMANS; MEMBRANE PROTEINS; MODELS, MOLECULAR; MYCOBACTERIUM TUBERCULOSIS; PEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES;

EID: 12344304227     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.08.046     Document Type: Article

References (35)

1. P.W. Roche, J.A. Triccas, and N. Winter BCG vaccination against tuberculosis: past disappointments and future hopes Trends Microbiol 3 1995 397 401
2. P.E. Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
3. H.G. Ten Dam Research on BCG vaccination Adv Tuberc Res 21 1984 79 106
4. M.E. Wilson, H.V. Fineberg, and G.A. Colditz Geographic latitude and the efficacy of Bacillus Calmette-Guerin vaccine Clin Infect Dis 20 1995 982 991
5. G.A. Colditz, T.F. Brewer, C.S. Berkey, M.E. Wilson, E. Burdick, and H.V. Fineberg Efficacy of BCG vaccine in the prevention of tuberculosis-meta- analysis of the published literature JAMA 271 1994 698 702
6. S.H.E. Kaufmann Is the development of new tuberculosis vaccine possible Nat Med 6 2000 955 960
7. R.L. Sepulveda, C. Parcha, and R.U. Sorensen Case-control study of the efficacy of BCG immunization against pulmonary tuberculosis in young adults in Santiago Chile Tuberc Lung Dis 73 1992 327 372
8. A. Van Rie, R. Warren, M. Richardson, T.C. Victor, R.P. Gie, and D.A. Enarson Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment N Engl J Med 341 1999 1174 1179
9. B.R. Bloom, and CJ.L. Murray Tuberculosis: commentary on a re-emergent killer Science 257 1992 1055 1064
10. S.T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, and D. Harris Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence Nature 393 1998 537 544
11. S. Sreevatsan, X. Pan, K.E. Stockbauer, N.D. Connell, B.N. Kreiswirth, and T.S. Whittam Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination Proc Natl Acad Sci USA 94 1997 9869 9874
12. L. Ramakrishnan, N.A. Federspiel, and S. Falkow Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family Science 288 2000 1436 1439
13. M.J. Brennan, G. Delogu, Y. Chen, S. Bardarov, J. Kriakov, and M. Alavi Evidence that mycobacterial PE_PGRS proteins are cell surface constituents that influence interactions with other cells Infect Immunol 69 2001 7326 7333
14. F. Tekaia, S.V. Gordon, T. Garnier, R. Brosch, B.G. Barrell, and S.T. Cole Analysis of the proteome of Mycobacterium tuberculosis in silico Tuberc Lung Dis 79 1999 329 342
15. S. Banu, N. Honore, B. Saint-Joanis, D. Philpott, M.C. Prevost, and S.T. Cole Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens? Mol Microbiol 44 2002 9 19
16. C. Abou-Zeid, T. Garbe, R. Lathigra, H.G. Wiker, M. Harboe, and G.A. Rook Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins Infect Immunol 59 1991 2712 2718
17. C. Espitia, J.P. Laclette, M. Mondragon-Palomino, A. Amador, J. Campuzano, and A. Martens The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: a new family of fibronectin-binding proteins Microbiology 145 1999 3487 3495
18. K.K. Singh, X. Zhang, A.S. Patibandla, Chien PJr, and S. Laal Antigens of Mycobacterium tuberculosis expressed during preclinical tuberculosis: serological immunodominance of proteins with repetitive amino acid sequences Infect Immunol 69 2001 4185 4191
19. D.C. Dillon, M.R. Alderson, C.H. Day, D.M. Lewinsohn, R. Coler, and T. Bement Molecular characterization and human T cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family Infect Immunol 67 1999 2941 2950
20. Y.A. Skeiky, P.J. Ovendale, S. Jen, M.R. Alderson, D.C. Dillon, and S. Smith T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection J Immunol 165 2000 7140 7149
21. G. Delogu, and M.J. Brennan Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis Infect Immunol 69 2001 5606 5611
22. Kaufmann SHE, and ChH. Ladel Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knockout mice with Listeria monocytogenes and Mycobacterium bovis BCG Immunobiol 191 1994 509 519
23. J.L. Flynn, M.M. Goldstein, K.J. Triebold, B. Koller, and B.R. Bloom Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection Proc Natl Acad Sci USA 89 1992 12013 12017
24. C.H. Ladel, S. Daugelat, and S.H. Kaufmann Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance Eur J Immunol 25 1995 377 384
25. A.A. Pathan, K.A. Wilkinson, R.J. Wilkinson, M. Latif, H. McShane, and G. Pasvol High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease Eur J Immunol 30 2000 2713 2721
26. + T lymphocytes specific for Mycobacterium tuberculosis Proc Natl Acad Sci USA 95 1998 270 275
27. + T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells J Exp Med 187 1998 1633 1640
28. + cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway J Immunol 162 1999 372 379
29. W. Martin, H. Sbai, and A.S. De Groot Bioinformatics tools for identifying class I-restricted epitopes Methods 29 2003 289 298
30. K.C. Parker, M.A. Bednarek, and J.E. Coligan Scheme for ranking potential HLA-A2-binding peptides based on independent binding of individual peptide side-chains J Immunol 152 1994 163 175
31. P. Anderson TB vaccines: progress and problems Trends Immunol 22 2001 160 168
32. D.R. Flower Towards in silico prediction of immunogenic epitopes Trends Immunol 24 2003 667 674
33. A. Sette, J. Sidney, M.F. del Guercio, S. Southwood, J. Ruppert, and C. Dahlberg Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays Mol Immunol 31 1994 813 822
34. G. Stuber, S. Modrow, P. Hoglund, L. Franksson, J. Elvin, and H. Wolf Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells Eur J Immunol 22 1992 2697 2703
35. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, and H. Weissig The protein data bank Nuc Acids Res 28 2000 235 242